COST

911.43

-0.96%↓

PG

150.62

+0.75%↑

KO

68.95

-0.07%↓

PM

144.27

-1.04%↓

PEP

146.12

-0.98%↓

COST

911.43

-0.96%↓

PG

150.62

+0.75%↑

KO

68.95

-0.07%↓

PM

144.27

-1.04%↓

PEP

146.12

-0.98%↓

COST

911.43

-0.96%↓

PG

150.62

+0.75%↑

KO

68.95

-0.07%↓

PM

144.27

-1.04%↓

PEP

146.12

-0.98%↓

COST

911.43

-0.96%↓

PG

150.62

+0.75%↑

KO

68.95

-0.07%↓

PM

144.27

-1.04%↓

PEP

146.12

-0.98%↓

COST

911.43

-0.96%↓

PG

150.62

+0.75%↑

KO

68.95

-0.07%↓

PM

144.27

-1.04%↓

PEP

146.12

-0.98%↓

Search

USANA Health Sciences Inc

Закрыт

21.2 7.29

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

20.89

Макс.

21.27

Ключевые показатели

By Trading Economics

Доход

1.2M

10M

Продажи

-22M

214M

P/E

Средняя по отрасли

11.552

29.661

Прибыль на акцию

-0.15

Рентабельность продаж

4.428

Сотрудники

1,700

EBITDA

-17M

11M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+84.4% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.6M

380M

Предыдущая цена открытия

13.91

Предыдущая цена закрытия

21.2

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 окт. 2025 г., 17:40 UTC

Приобретения, слияния, поглощения

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

31 окт. 2025 г., 23:09 UTC

Отчет

Review & Preview: October Surprise -- Barrons.com

31 окт. 2025 г., 22:44 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 окт. 2025 г., 21:25 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 окт. 2025 г., 21:20 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 окт. 2025 г., 21:12 UTC

Приобретения, слияния, поглощения

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 окт. 2025 г., 20:51 UTC

Приобретения, слияния, поглощения

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

31 окт. 2025 г., 20:50 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

31 окт. 2025 г., 20:46 UTC

Приобретения, слияния, поглощения

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 окт. 2025 г., 20:22 UTC

Отчет

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 окт. 2025 г., 20:02 UTC

Отчет

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 окт. 2025 г., 19:55 UTC

Обсуждения рынка

Crude Futures Fall for Third Straight Month -- Market Talk

31 окт. 2025 г., 19:54 UTC

Приобретения, слияния, поглощения

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 окт. 2025 г., 19:54 UTC

Приобретения, слияния, поглощения

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 окт. 2025 г., 19:26 UTC

Обсуждения рынка

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 окт. 2025 г., 18:30 UTC

Отчет

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 окт. 2025 г., 18:23 UTC

Обсуждения рынка

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 окт. 2025 г., 18:09 UTC

Отчет

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 окт. 2025 г., 18:08 UTC

Отчет

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 окт. 2025 г., 17:36 UTC

Обсуждения рынка

Grain Futures Shrug Off Stronger Dollar -- Market Talk

31 окт. 2025 г., 17:31 UTC

Обсуждения рынка

U.S. Oil Rig Count Falls, Natural Gas Rig Count Rises -- Market Talk

31 окт. 2025 г., 17:16 UTC

Приобретения, слияния, поглощения

Orange: Acquisition Likely Completed in First Half Next Year

31 окт. 2025 г., 17:15 UTC

Приобретения, слияния, поглощения

Orange: Agreement Set to Be Signed By Year-Out

31 окт. 2025 г., 17:14 UTC

Приобретения, слияния, поглощения

Orange: Acquisition Will Strengthen Position in Spain

31 окт. 2025 г., 17:13 UTC

Приобретения, слияния, поглощения

Orange Will Be Sole Owner of Spain's MasOrange Following Acquisition of Lorca's Stake

31 окт. 2025 г., 17:12 UTC

Приобретения, слияния, поглощения

Orange Reaches Deal to Buy Lorca's 50% Stake in MasOrange for EUR4.25B

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Целевая цена

By TipRanks

84.4% рост

Прогноз на 12 месяцев

Средняя 39 USD  84.4%

Максимум 39 USD

Минимум 39 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для USANA Health Sciences Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat